iShares Neuroscience and HeaIBRNETF
13F holders, Q2 2024 (June 30)4holders
1new positions
1sold out
$23.58avg. 13F price*
At the end of Q2 2024, 4 institutions reported holding iShares Neuroscience and Hea (IBRN) in their 13F filings, unchanged from Q1 2024. 1 opened new positions and 1 sold out. The largest holders were BlackRock Inc. ($2.2M), Flow Traders U.S. LLC ($410K) and Bank of Montreal ($17K).
- Company
- iShares Neuroscience and Hea
- CUSIP
- 46436E353
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $2K |
| Exits | 1 | $480K |
All 13F filers, Q1 2024 → Q2 2024: 7,840 shares bought and 20,272 shares sold, net −12,432 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| BlackRock Inc. | 0.00% | No change | 95,000 | $2.2M |
| Flow Traders U.S. LLC | 0.02% | Add +80.5% | 17,371 | $410K |
| Bank of Montreal | 0.00% | Reduce -67.4% | 734 | $17K |
| Family Firm, Inc. | 0.00% | New | 91 | $2K |
"% of holder's portfolio" is IBRN's weight in each manager's 13F, not the share of iShares Neuroscience and Hea the manager owns.